Fournier Pllc Stephenson - 10% Owner before reverse split at NANOVIRICIDES, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Fournier Pllc Stephenson since 13 Sep 2025

Reported holdings for Fournier Pllc Stephenson in NANOVIRICIDES, INC.

Form 4 holding 10% Owner before reverse split

NANOVIRICIDES, INC.

Security class
Common Stock, par value $0.001 per share
Shares / value
343,135
Estimated value
Report date
21 Feb 2017
Price
Ownership
Milton Boniuk IRA
Form 4 holding 10% Owner before reverse split

NANOVIRICIDES, INC.

Security class
Common Stock, par value $0.001 per share
Shares / value
138,843
Estimated value
Report date
21 Feb 2017
Price
Ownership
Boniuk Interests Ltd
Form 4 holding 10% Owner before reverse split

NANOVIRICIDES, INC.

Security class
Series A Convertible Preferred Stock
Shares / value
16,850
Estimated value
Report date
21 Feb 2017
Price
Ownership
Held by the Milton Boniuk IRA
Underlying class
Common Stock
Underlying amount
58,975
Form 4 holding 10% Owner before reverse split

NANOVIRICIDES, INC.

Security class
Common Stock, par value $0.001 per share
Shares / value
9,743
Estimated value
Report date
21 Feb 2017
Price
Ownership
Direct

Transaction history for Fournier Pllc Stephenson in NANOVIRICIDES, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .